SFX by Ex Libris Inc.

Title:	The Yin and Yang of T cell costimulation
Source:	Science [0036-8075] Allison, J P yr:1995

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sharpe, Arlene H. H. "T-Cell Costimulation — Biology, Therapeutic Potential, and Challenges." The New England journal of medicine 355.10 (2006): 973-975.
description	2.	Chambers, C A A. "The role of CTLA-4 in the regulation and initiation of T-cell responses." Immunological reviews 153.1 (1996): 27-46.
description	3.	Vanneman, M. "Combining immunotherapy and targeted therapies in cancer treatment." Nature Reviews. Cancer 12.4 (2012): 237-251.
description	4.	Schraven, B. "CD28 superagonists: what makes the difference in humans?" Immunity 28.5 (2008): 591-5.
description	5.	So, K S L. "Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis." Osteoarthritis and cartilage 9.SUPPL. A (2001): 160-73.
description	6.	Leach, D R R. "Enhancement of antitumor immunity by CTLA-4 blockade." Science 271.5256: 1734-1736.
description	7.	Alderton, Yvonne K. "Tumour immunotherapy—leukocytes take up the fight." Nature reviews. Immunology 12.4 (2012): 237-237.
description	8.	Palucka, K. "Cancer immunotherapy via dendritic cells." Nature Reviews. Cancer 12.4 (2012): 265-277.
description	9.	Restifo, Nicholas P. "Adoptive immunotherapy for cancer: harnessing the T cell response." Nature reviews. Immunology 12.4 (2012): 269-281.
description	10.	Pardoll, Drew M. "The blockade of immune checkpoints in cancer immunotherapy." Nature Reviews. Cancer 12.4 (2012): 252-264.
description	11.	Mellman, I. "Cancer immunotherapy comes of age." Nature 480.7378 (2011): 480-489.
description	12.	Kwon, E D D. "Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer." Proceedings of the National Academy of Sciences of the United States of America 94.15 (1997): 8099-103.
description	13.	Hodi, Steven S. "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma." New England Journal of Medicine, The 363.8 (2010): 711-723.
description	14.	Tufet, M. "T-cell activation: The waves behind the TGN1412 storm." Nature reviews. Immunology 8.5 (2008): 322-323.
description	15.	Gladue, R P P. "The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma." Cancer immunology, immunotherapy 50.3 (2001): 125-33.
description	16.	Honjo, T. "Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death." The EMBO journal 11.11 (1992): 3887-95.
description	17.	Bhardwaj, N. "Plasma Factors during Chronic HIV-1 Infection Impair IL-12 Secretion by Myeloid Dendritic Cells via a Virus-Independent Pathway." Journal of acquired immune deficiency syndromes 61.5 (2012): 535-544.
description	18.	Wang, J. "Effect of triptolide on T-cell receptor beta variable gene mRNA expression in rats with collagen-induced arthritis." The anatomical record (2012): 922-927.
description	19.	Hnig, K. "Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice." PloS one 4.2 (2009).
description	20.	St Clair, E William W. "The calm after the cytokine storm: lessons from the TGN1412 trial." The journal of clinical investigation 118.4 (2008): 1344-7.